Ersilia Vita Fiscarelli
Overview
Explore the profile of Ersilia Vita Fiscarelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Changes in the pharyngeal and nasal microbiota in pediatric patients with adenotonsillar hypertrophy
Del Chierico F, Piazzesi A, Fiscarelli E, Ristori M, Pirona I, Russo A, et al.
Microbiol Spectr
. 2024 Sep;
12(10):e0072824.
PMID: 39248478
Importance: Adenotonsillar hypertrophy (AH) is considered the main cause of breathing disorders during sleep in children. AH patients, after significant morbidity and often multiple courses of antibiotics, often proceed to...
2.
Del Chierico F, Marzano V, Scanu M, Reddel S, Dentici M, Capolino R, et al.
Sci Rep
. 2023 Jun;
13(1):9797.
PMID: 37328513
Williams-Beuren syndrome (WBS) is a multisystem genetic disease caused by the deletion of a region of 1.5-1.8 Mb on chromosome 7q11.23. The elastin gene seems to account for several comorbidities...
3.
Artini M, Imperlini E, Buonocore F, Relucenti M, Porcelli F, Donfrancesco O, et al.
Int J Mol Sci
. 2022 Nov;
23(21).
PMID: 36362282
is an opportunistic pathogen causing several chronic infections resistant to currently available antibiotics. Its pathogenicity is related to the production of different virulence factors such as biofilm and protease secretion....
4.
Artini M, Vrenna G, Trecca M, Tuccio Guarna Assanti V, Fiscarelli E, Papa R, et al.
Int J Mol Sci
. 2022 Oct;
23(20).
PMID: 36293502
is frequently involved in cystic fibrosis (CF) airway infections. Biofilm, motility, production of toxins and the invasion of host cells are different factors that increase virulence. The sessile phenotype offers...
5.
Montemari A, Manco M, Fiocchi A, Bartoli M, Facchiano F, Tabolacci C, et al.
J Inflamm Res
. 2022 Oct;
15:5677-5685.
PMID: 36238762
Objective And Design: Cystic fibrosis-related diabetes (CFRD) is a severe complication associated with increased morbidity and mortality in cystic fibrosis (CF) patients. Extensive inflammatory state in CF leads to pancreas...
6.
Artini M, Papa R, Sapienza F, Bozovic M, Vrenna G, Tuccio Guarna Assanti V, et al.
Microorganisms
. 2022 May;
10(5).
PMID: 35630332
The opportunistic pathogen is often involved in airway infections of cystic fibrosis (CF) patients. It persists in the hostile CF lung environment, inducing chronic infections due to the production of...
7.
Montemari A, Marzano V, Essa N, Mortera S, Rossitto M, Gardini S, et al.
Front Med (Lausanne)
. 2022 Mar;
9:818669.
PMID: 35355602
Cystic fibrosis (CF) is the most common rare disease caused by a mutation of the gene encoding a channel protein of the apical membrane of epithelial cells leading to alteration...
8.
Luberto L, Neroni B, Gandini O, Fiscarelli E, Salvatori G, Roscilli G, et al.
Front Microbiol
. 2022 Jan;
12:789774.
PMID: 34975811
The COVID-19 pandemic has highlighted genetic vaccination as a powerful and cost-effective tool to counteract infectious diseases. Invasive fungal infections (IFI) remain a major challenge among immune compromised patients, particularly...
9.
Vrenna G, Artini M, Ragno R, Relucenti M, Fiscarelli E, Tuccio Guarna Assanti V, et al.
Microorganisms
. 2021 Nov;
9(11).
PMID: 34835383
is an opportunistic pathogen responsible for nosocomial infections, and is often involved in airway infections of cystic fibrosis (CF) patients. virulence is related to its ability to form biofilm, trigger...
10.
Degiacomi G, Chiarelli L, Recchia D, Petricci E, Gianibbi B, Fiscarelli E, et al.
Int J Mol Sci
. 2021 Aug;
22(16).
PMID: 34445239
Some nontuberculous mycobacteria (NTM) are considered opportunistic pathogens. Nevertheless, NTM infections are increasing worldwide, becoming a major public health threat. Furthermore, there is no current specific drugs to treat these...